[1] Molyvda-Athanasopoulou E, Karlatira M, Gotzamani-Psarrakou A, et al. Radiation exposure to patients and radiologists during interventional procedures[J]. Radiat Prot Dosimetry, 2011, 147: 86-89.
[2] Fazel R, Krumholz HM, Wang Y. Exposure to low-dose ionizing radiation from medical imaging procedures[J]. N Engl J Med, 2009, 361: 849-857
[3] Buijs M, Vossen JA, Frangakis C, et al. Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization: single-center experience[J]. Radiology, 2008, 249: 346-354.
[4] Caldwell S, Park SH. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology[J]. J Gastroenterol, 2009, 44: 96-101.
[5] 董家鸿, 郑树森, 陈孝平, 等. 肝切除术前肝脏储备功能评估的专家共识(2011版)[J]. 中华消化外科杂志, 2011, 10: 20-25.
[6] Shimohira M, Ogino H, Kawai T, et al. Use of the triaxial microcatheter method in super-selective transcatheter arterial chemoembolisation for hepatocellular carcinoma[J]. Br J Radiol, 2011, 84: 184-187.
[7] 徐力扬, 李京雨, 刘 明, 等. 吡柔比星-碘油乳剂不同配比特性的实验研究[J]. 中国肿瘤临床, 2002, 29: 38-40.
[8] 吴安乐, 颜志平, 周康荣, 等. 经动脉内灌注利多卡因-碘油乳剂在恶性肿瘤栓塞化疗术中止痛疗效的评价[J]. 介入放射学杂志, 2004, 13: 250-252.
[9] 龙清云, 刘骏方, 鲁植艳, 等. 利多卡因在肝癌化疗栓塞中的临床应用[J]. 放射学实践, 2002, 17: 305-306.